Dalzanemdor
N/A
Report date: 2025/07/04 17:49:18
NME
Base Information
Drug NameDalzanemdor
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSage Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesSupernus Pharmaceuticals Inc
Inactive CompaniesSage Therapeutics Inc
Active Indications +[4]
Inactive Indications